Determinants of direct and indirect costs in anorexia nervosa.

OBJECTIVE To estimate direct and indirect costs of anorexia nervosa (AN), and to identify cost determinants. METHODS In a subsample (n = 225) of the ANTOP trial (Anorexia Nervosa Treatment of OutPatients) health care utilization and productivity losses were assessed at baseline for the previous 3 months and monetarily valued. Included were females aged 18 years and older diagnosed with AN or subsyndromal AN, and a body mass index (BMI) between 15 and 18.5 kg/m(2) . To account for missing data multiple imputation was employed. Cost determinants were derived from generalized linear models with gamma distribution and log link function. RESULTS Mean 3-months costs per patient amounted to €5,866 (SE = €576). The largest share of costs (€3,374) resulted from hospitalizations. Determinants of direct costs were analyzed separately for those with hospitalizations for AN, and those without. In the group only treated as outpatients, participants with binge/purge subtype, and those diseased for more than 6 years had higher costs. Moreover, costs were increased in patients with a comorbid mental disorder. In the group with hospitalizations, direct costs increased with BMI. BMI was measured at the end of the observation period, indicating that longer duration of treatment yielded higher weight gain. Indirect costs were not significantly associated with any disease-related characteristic. DISCUSSION Costs resulting from health care utilization and productivity loss are substantial, although the sample studied had not received sufficient treatment. Future research should analyze the development of costs over time.

[1]  C. Schade-Brittinger,et al.  Focal psychodynamic therapy, cognitive behaviour therapy, and optimised treatment as usual in outpatients with anorexia nervosa (ANTOP study): randomised controlled trial , 2014, The Lancet.

[2]  H. Hoek,et al.  Epidemiology of Eating Disorders: Incidence, Prevalence and Mortality Rates , 2012, Current Psychiatry Reports.

[3]  B. Löwe,et al.  Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review. , 2012, The International journal of eating disorders.

[4]  B. Klapp,et al.  Inpatient costs and predictors of costs in the psychosomatic treatment of anorexia nervosa. , 2012, The International journal of eating disorders.

[5]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[6]  W. Maier,et al.  Net costs of dementia by disease stage , 2011, Acta psychiatrica Scandinavica.

[7]  J. Seitz,et al.  Kindliche und adoleszente Anorexia nervosa , 2011, Der Nervenarzt.

[8]  A. Hartmann,et al.  Psychological Treatment for Anorexia Nervosa: A Meta-Analysis of Standardized Mean Change , 2011, Psychotherapy and Psychosomatics.

[9]  S. Hagen,et al.  Presenteeism: Critical Issues , 2010, Journal of occupational and environmental medicine.

[10]  K. Webb,et al.  Treating eating disorders: a review of the evidence , 2010, Evidence Based Mental Health.

[11]  James E Mitchell,et al.  Health care utilization in patients with eating disorders. , 2009, The International journal of eating disorders.

[12]  A. Konnopka,et al.  [The cost of schizophrenia in Germany: a systematic review of the literature]. , 2009, Psychiatrische Praxis.

[13]  Herbert Matschinger,et al.  Service utilization and health-care costs in the advanced elderly. , 2008, Value in Health.

[14]  T. Luck,et al.  Direct costs associated with mild cognitive impairment in primary care , 2007, International journal of geriatric psychiatry.

[15]  J. Graham,et al.  How Many Imputations are Really Needed? Some Practical Clarifications of Multiple Imputation Theory , 2007, Prevention Science.

[16]  J. Wasem,et al.  Empirische Bewertungssätze in der gesundheitsökonomischen Evaluation – ein Vorschlag der AG Methoden der gesundheitsökonomischen Evaluation (AG MEG). , 2005 .

[17]  Paul E. Stang,et al.  Using the World Health Organization Health and Work Performance Questionnaire (HPQ) to Evaluate the Indirect Workplace Costs of Illness , 2004, Journal of occupational and environmental medicine.

[18]  Anirban Basu,et al.  Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data , 2003, Journal of health economics.

[19]  B. Löwe,et al.  Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study , 2001, Psychological Medicine.

[20]  R. Rosenheck,et al.  One-year use and cost of inpatient and outpatient services among female and male patients with an eating disorder: evidence from a national database of health insurance claims. , 2000, The International journal of eating disorders.

[21]  Deborah Lynn Reas,et al.  Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study , 2000, The Lancet.

[22]  M J Buxton,et al.  Assessing the costs of healthcare technologies in clinical trials. , 1999, Health technology assessment.

[23]  J L Schafer,et al.  Multiple Imputation for Multivariate Missing-Data Problems: A Data Analyst's Perspective. , 1998, Multivariate behavioral research.

[24]  W. Herzog,et al.  Anorexia nervosa in a long‐term perspective: results of the Heidelberg‐Mannheim Study. , 1994, Psychosomatic medicine.

[25]  S. Riedel-Heller,et al.  Direct costs associated with depression in old age in Germany. , 2008, Journal of affective disorders.

[26]  A. Basu,et al.  Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. , 2005, Biostatistics.

[27]  K. Buser,et al.  How high are the costs of eating disorders - anorexia nervosa and bulimia nervosa – for German society? , 2002, The European Journal of Health Economics.